Comprehensive insulin signalling map shows interplay between genes and diet

Researchers have produced a comprehensive picture of insulin signalling in mice and suggest that it is shaped by entangled effects of genetics and diet. 

The research, published today as a Reviewed Preprint in eLife, is described by the editors as a fundamental study of substantial importance. They say the authors share compelling evidence that sheds light on the interplay between genetic attributes and environmental conditions in shaping insulin signalling in skeletal muscle – a crucial regulator of metabolism. The study also provides a unique tool for assessing the range of phosphorylation in insulin reactions and is anticipated to provide inspiration for further research into metabolic disease and diabetes. 

“Insulin resistance – the failure of insulin to promote glucose uptake in its target tissues – is triggered by genetic and environmental factors such as family history and high-calorie diets,” says lead author Julian van Gerwen, during the study an undergraduate at the School of Life and Environmental Sciences, University of Sydney, Australia. “Although insulin resistance is a major precursor of metabolic disease, including type 2 diabetes, its mechanistic basis remains unresolved.” 

Insulin normally tells the body to absorb glucose (sugar) from the bloodstream via a complex and dynamic signalling pathway. These signals are enabled by a process called phosphorylation – the addition of a phosphate group to a protein at a very specific position (called a phosphosite). 

It is thought that insulin signalling controls thousands of phosphosites, but many are still uncharacterised. In addition, although it is well known that individual people vary greatly in their physiological response to insulin, it remains unclear how genetics or diet influence the phosphorylation status of cellular proteins – also known as the phosphoproteome. 

To address this, van Gerwen and colleagues studied mice with well-characterised but different genetic backgrounds, so they could decipher the specific effects of genetics and diet on insulin signalling. They fed five strains of mice either a normal or high-fat and high-sugar diet, and took samples of their skeletal muscle – the site of greatest insulin-triggered glucose uptake after eating. Then they measured phosphorylation of the thousands of proteins present in each muscle sample using mass spectrometry. Their analysis recovered many well-known insulin-regulated phosphosites, and many more novel sites that had not previously been associated with insulin signalling. 

To explore the influence of genetic and environmental variation, the team developed an algorithm to analyse which changes could be attributed to genetics, diet, or their combination. Almost half of all insulin-regulated phosphosites were affected by the strain of the mice when fed a normal diet, either having a stronger or weaker response to insulin. Overall, each genetic background displayed a unique fingerprint of insulin signalling. 

By contrast, although there were changes in insulin signalling caused by diet, the vast majority of these were shaped by the genetic background of the mice. Many phosphosites even changed in the opposite direction between multiple strains, highlighting that the molecular impacts of a high-fat diet are strongly controlled by genetics. 

To explore whether these changes in phosphorylation amounted to an altered insulin response in the mice, the team also measured glucose uptake in the same muscles used for the phosphoproteome analysis. By linking all insulin-regulated phosphosites with the level of glucose uptake, the researchers narrowed down on a set of key phosphosites likely to control the insulin response. Inspired by one of these phosphosites, the team found that modulating a specific protein could reverse insulin resistance in a cell-based model. 

The authors point out that the genetic and diet-driven changes in phosphorylation largely could not be predicted by the current model of the insulin signalling pathway. This highlights that our

knowledge of this pathway is far from complete, and they say that the next step is to investigate

underlying biomolecular mechanisms that could link common changes. They also suggest that

incorporating female mice and a wider range of genetic backgrounds will strengthen their

research.

“The protein phosphorylation landscape is vast and intricate, akin to a night sky filled with stars,”

explains senior author David James, a professor at the School of Life and Environmental Sciences

and Faculty of Medicine and Health, University of Sydney. “Many teams have sought to organise

these stars into constellations and chart those that collapse in disease. However, most have only

used cell lines and lab animals of limited genetic backgrounds. In this study, when we examined

genetic and environmental variation – as occurs in the human population – we observed a

complete rearrangement of the night sky, marked by a fading of the familiar constellations and the

emergence of entirely new galaxies. To truly comprehend how diseases manifest from signalling

aberrations, we must adapt to this newfound complexity. Our work provides a launching pad for

future studies to tackle this complexity for insulin resistance and diabetes.”

##

Media contacts 

Emily Packer, Media Relations Manager

eLife

e.packer@elifesciences.org

01223 855373

George Litchfield, Marketing and PR Assistant

eLife

g.litchfield@elifesciences.org

About eLife

eLife transforms research communication to create a future where a diverse, global community of scientists and researchers produces open and trusted results for the benefit of all. Independent, not-for-profit and supported by funders, we improve the way science is practised and shared. In support of our goal, we have launched a new publishing model that ends the accept/reject decision after peer review. Instead, papers invited for review will be published as a Reviewed Preprint that contains public peer reviews and an eLife assessment. We also continue to publish research that was accepted after peer review as part of our traditional process. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.

To read the latest Computational and Systems Biology research published in eLife, visit https://elifesciences.org/subjects/computational-systems-biology.

---

---